<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Novavax Inc (NASDAQ: NVAX) has completed its rolling submission to Health Canada for the authorization of its protein-based COVID-19 vaccine candidate. In addition, the Company has completed the submission of all data and modules to the European Medicines Agency (EMA) to support the final regulatory review of its dossier.
...read full article on Benzinga
